Evidence map›Paper›PMID 29861421›Full record

ArticleNon-coding RNA2015

Stabilization of Urinary MicroRNAs by Association with Exosomes and Argonaute 2 Protein.

Cristina Beltrami, Aled Clayton, Lucy J Newbury, Peter Corish, Robert H Jenkins, Aled O Phillips, Donald J Fraser, Timothy Bowen

Open access · goldAbstract read
In one paragraph

Article in Non-coding RNA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Extracellular vesicles: The next generation in gene therapy delivery.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  7. The Multiplicity of Argonaute Complexes in Mammalian Cells.The Journal of pharmacology and experimental therapeutics · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Cristina BeltramiDepartment of Nephrology, Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. c.beltrami@bristol.ac.uk.
Aled ClaytonSection of Oncology and Palliative Medicine, Institute of Cancer and Genetics, School of Medicine, College of Biomedical and Life Sciences, Velindre Hospital, Heath Park, Cardiff CF14 2TL, UK. claytona@cf.ac.uk.
Lucy J NewburyDepartment of Nephrology, Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. newburyl@cf.ac.uk.
Peter CorishBBI Group, The Courtyard, Ty Glas Avenue, Cardiff CF14 5DX, UK. PeterCorish@the-bbigroup.com.
Robert H JenkinsDepartment of Nephrology, Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. jenkinsrh2@cf.ac.uk.
Aled O PhillipsDepartment of Nephrology, Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. phillipsao@cf.ac.uk.
Donald J FraserDepartment of Nephrology, Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. fraserdj@cf.ac.uk.
Timothy BowenDepartment of Nephrology, Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. bowent@cf.ac.uk.
Cardiff University · GBVelindre Cancer Centre · GB

Funding

Department of Health II-LA-0712-20003
6 · The paper itself

Abstract

A pressing need for new chronic kidney disease (CKD) biomarkers persists. MicroRNAs (miRNAs) are emerging as a novel class of disease biomarkers in body fluids, but mechanisms conferring their stability in urine have not been fully elucidated. Here we investigated stabilization in human urine of ubiquitously expressed miR-16, and miR-192, which we have shown previously to be downregulated in renal fibrosis, by association with extracellular vesicles and with argonaute protein (AGO) 2. Endogenous urinary miR-16 was significantly more resistant to RNase-mediated degradation than exogenous, spiked-in,

Indexed as

AGO2biomarkerchronic kidney diseaseexosomemicroRNAsurine

Identifiers

PMID29861421
PMCPMC5932545
OpenAlexW1864664415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.